Threshold of oestrogen and progesterone for endocrine therapy

In women with invasive breast cancer, the ECIBC's Guidelines Development Group (GDG) suggests:

  • administration of adjuvant endocrine therapy if 1% or greater of tumour cells show oestrogen receptor positivity rather than applying a threshold of 10% tumour cell oestrogen receptor positivity
    (conditional recommendation, very low certainty of the evidence)
  • administration of adjuvant endocrine therapy if 1% or greater of tumour cells show progesterone receptor positivity rather than applying a threshold of 10% tumour cell progesterone receptor positivity (conditional recommendation, very low certainty of the evidence).

MORE INFORMATION